Onconetix (ONCO) Receivables - Other (2021 - 2026)

Onconetix (ONCO) has reported Receivables - Other for 6 consecutive years, with $6172.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Other fell 51.01% year-over-year to $6172.0 in Q2 2026; TTM through Jun 2026 was $6172.0, a 51.01% decrease from a year earlier, with the FY2025 full-year figure at $300000.0, up 617.1% from the prior year.
• Receivables - Other was $6172.0 for Q2 2026 at Onconetix, up from -$50000.0 in the prior quarter.
• Over five years, Receivables - Other peaked at $522000.0 in Q3 2023 and troughed at -$50000.0 in Q1 2026.
• A 5-year average of $131722.4 and a median of $38842.5 in 2022 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other surged 1391.43% in 2023 and plunged 552.2% in 2026, its largest moves.
• Over 5 years, Receivables - Other stood at $35850.0 in 2022, then jumped by 343.51% to $159000.0 in 2023, then plunged by 73.69% to $41835.0 in 2024, then advanced by 19.52% to $50000.0 in 2025, then plunged by 87.66% to $6172.0 in 2026.
• The last three Receivables - Other figures came in at $6172.0 (Q2 2026), -$50000.0 (Q1 2026), and $50000.0 (Q4 2025), per Business Quant data.